drugset / Trial / NCT02387450
Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
RandomizedParallel-groupTriple-blindTreatment
Summary
Sildenafil has shown potential effects both on vasodilator mechanisms and as an inhibitor of the NO/GMPc Pain activation. The investigators aim at estimating the benefit of sildenafil in term of morbi-mortality in patients with arterial claudication on a multicenter prospective double blind study.
Timeline
- Start
- 2015-09
- Primary completion
- 2017-06
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sildenafil | Unknown | 100 mg | Oral |